论文部分内容阅读
酮基布洛芬(KetoProfen,简称KP),是1967年由hbntpoulen研制的一种非甾体抗炎,解热镇痛新药。1972年在英,法出售。1980年西南合成制药厂仿制成功,经药理实验及临床应用,均获得满意的疗效,但对其毒性了解还不够充分,为此,我们做了KP的急性和亚急性毒性实验,并与消炎痛(Indomethacin,简称IND)进行对比观察,现将实验结果报告如下:
KetoProfen (KetoProfen, referred to as KP), is a 1967 by hbntpoulen developed a non-steroidal anti-inflammatory, anti-inflammatory drugs. 1972 in Britain, France for sale. In 1980, Southwest Synthetic Pharmaceutical Factory succeeded in imitation and achieved satisfactory results through pharmacological experiments and clinical application. However, its toxicity was not fully understood. Therefore, we conducted acute and subacute toxicity experiments with KP and compared it with indomethacin (Indomethacin, IND for short), the experimental results are reported as follows: